IRS1 genotype modulates metabolic syndrome reversion in response to 2-year weight-loss diet intervention: The POUNDS LOST trial

Diabetes Care

Volumn 36, Issue 11, 2013, Pages 3442-3447

  Qi, Qibin ^a   Xu, Min ^a   Wu, Hongyu ^a   Liang, Liming ^a   Champagne, Catherine M ^b   Bray, George A ^b   Sacks, Frank M ^a   Qi, Lu ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; GENOTYPE DIET INTERACTION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID DIET; LOW FAT DIET; MACRONUTRIENT; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; REVERTANT; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT CHANGE; WEIGHT REDUCTION; CALORIC INTAKE; DIET THERAPY; GENETICS; LOW CALORY DIET; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, HUMAN;

ADULT; ALLELES; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; DIET, REDUCING; ENERGY INTAKE; FEMALE; GENOTYPE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; WEIGHT LOSS;

EID: 84891863955     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0018     Document Type: Article

References (27)

1. Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NECP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497
2. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-414
3. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005;28:2823-2831
4. Esposito K, Marfella R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 292:1440-1446
5. Kukkonen-Harjula KT, Borg PT,Nenonen AM, Fogelholm MG. Effects of a weight maintenance program with or without exercise on the metabolic syndrome: a randomized trial in obese men. Prev Med 2005;41:784-790
6. Salas-Salvadó J, Fernandez-Ballart J, Ros E, et al.; PREDIMED Study Investigators. Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Intern Med 2008; 168:2449-2458
7. Wu H, Pan A, Yu Z, et al. Lifestyle counseling and supplementation with flaxseed or walnuts influence the management of metabolic syndrome. J Nutr 2010;140: 1937-1942
8. Wood RJ, Fernandez ML. Carbohydraterestricted versus low-glycemic-index diets for the treatment of insulin resistance and metabolic syndrome. Nutr Rev 2009;67: 179-183
9. Riccardi G, Rivellese AA. Dietary treatment of the metabolic syndromedthe optimal diet. Br J Nutr 2000;83(Suppl. 1): S143-S148
10. Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009;360: 859-873
11. Sun XJ, Rothenberg P, Kahn CR, et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991;352:73-77
12. Araki E, Lipes MA, Patti M-E, et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994;372:186-190
13. Tamemoto H, Kadowaki T, Tobe K, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 1994;372:182-186
14. Kilpeläinen TO, ZillikensMC, Stancakova A, et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 2011;43:753-760
15. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466:707-713
16. Rung J, Cauchi S, Albrechtsen A, et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 2009; 41:1110-1115
17. Samani NJ, Erdmann J, Hall AS, et al.; WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl J Med 2007;357:443-453
18. Qi Q, Bray GA, Smith SR, Hu FB, Sacks FM, Qi L. Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation 2011; 124:563-571
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419
20. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36: 936-942
21. He MA, Workalemahu T, Cornelis MC, Hu FB, Qi L. Genetic variants near the IRS1 gene, physical activity and type 2 diabetes in US men and women. Diabetologia 2011;54:1579-1582
22. Qi Q, Bray GA, Hu FB, Sacks FM, Qi L. Weight-loss dietsmodify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in bodyweight, fasting glucose, and insulin resistance: the Preventing OverweightUsingNovelDietary Strategies trial. Am J Clin Nutr 2012;95: 506-513
23. Zhang X, Qi Q, Bray GA, Hu FB, Sacks FM,Qi L. APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial. AmJ ClinNutr 2012;96:917-922
24. Zhang X, Qi Q, Zhang C, et al. FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial. Diabetes 2012;61:3005-3011
25. Mattei J, Qi Q, Hu FB, Sacks FM, Qi L. TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention. Am J Clin Nutr 2012;96: 1129-1136
26. Zhang X, Qi Q, Liang J, Hu FB, Sacks FM, Qi L. Neuropeptide Y promoter polymorphism modifies effects of a weightloss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial. Hypertension 2012;60:1169-1175
27. Marin C, Pérez-Martinez P, Delgado-Lista J, et al. The insulin sensitivity response is determined by the interaction between the G972R polymorphism of the insulin receptor substrate 1 gene and dietary fat. Mol Nutr Food Res 2011;55:328-335 Diseases